Molecular epidemiology of acute hepatitis B in the Netherlands in 2004: Nationwide survey

Journal of Medical Virology

Volumn 79, Issue 7, 2007, Pages 895-901

  Van Houdt, R ^a   Bruisten, S M ^a,b   Koedijk, F D H ^c   Dukers, N H T M ^a,b   Op De Coul, E L M ^c   Mostert, M C ^d   Niesters, H G M ^e   Richardus, J H ^d,e   De Man, R A ^e   Van Doornum, G J J ^e   Van Den Hoek, J A R ^a   Coutinho, R A ^b,c   Van De Laar, M J W ^c   Boot, H J ^c  

^a DEPARTMENT OF INFECTIOUS DISEASES   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d Public Health Service of the Rotterdam Region   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hepatitis B virus; Low endemic country; Molecular epidemiology; S gene; Transmission networks

Indexed keywords

ACUTE DISEASE; ARTICLE; FEMALE; GENE AMPLIFICATION; GENE CLUSTER; GENE SEQUENCE; GENETIC HETEROGENEITY; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MOLECULAR EPIDEMIOLOGY; NETHERLANDS; NONHUMAN; PHYLOGENY; SEXUAL TRANSMISSION; VIRUS GENE; VIRUS ISOLATION; VIRUS STRAIN; VIRUS TRANSMISSION;

ACUTE DISEASE; ADULT; BASE SEQUENCE; DNA PRIMERS; DNA, VIRAL; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PHYLOGENY;

HEPATITIS B VIRUS;

EID: 34249905235     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20820     Document Type: Article

References (20)

1. Arauz-Ruiz P, Norder H, Robertson BH, Magnius LO. 2002. Genotype H: a new Amerindian genotype of hepatitis B virus revealed in Central America. J Gen Virol 83:2059-2073.
2. Christensen PB, Krarup HB, Niesters HG, Norder H, Schaffalitzky de Muckadell OB, Jeune B, Georgsen J. 2001. Outbreak of hepatitis B among injecting drug users in Denmark. J Clin Virol 22:133-141.
3. Dukers NH, Goudsmit J, De Wit JB, Prins M, Weverling GJ, Coutinho RA. 2001. Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS 15:369-378.
4. Dukers NH, Spaargaren JF, Geskus RB, Beijnen JF, Coutinho RA, Fennema HS. 2002. HIV incidence on the increase among homosexual men attending an Amsterdam sexually transmitted disease clinic: using a novel approach for detecting recent infections. AIDS 16:F19-F24.
5. Fisker N, Pedersen C, Lange M, Nguyen NT, Nguyen KT, Georgsen J, Christensen PB. 2004. Molecular epidemiology of hepatitis B virus infections in Denmark. J Clin Virol 31:46-52.
6. Hahne S, Ramsay M, Balogun K, Edmunds WJ, Mortimer P. 2004. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy. J Clin Virol 29:211-220.
7. Hall TA. 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl Acids Symp Ser 41:95-98.
8. Koedijk FDH, Op de Coul ELM, Van de Laar MJ. 2005. Aangifte acute hepatitis B in 2003. Infect Bull 16:15-17.
9. Koppelman MH, Zaaijer HL. 2004. Diversity and origin of hepatitis B virus in Dutch blood donors. J Med Virol 73:29-32.
10. Kumar S, Tamura K, Nei M. 2004. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief Bioinform 5:150-163.
11. Lindenburg CE, Krol A, Smit C, Buster MC, Coutinho RA, Prins M. 2006. Decline in HIV incidence and injecting, but not in sexual risk behaviour, seen in drug users in Amsterdam: a 19-vear prospective cohort study. AIDS 20:1771-1775.
12. Magnius LO, Norder H. 1995. Subtypes, genotypes and molecular epidemiology of the hepatitis B virus as reflected by sequence variability of the S-gene. Intervirology 38:24-34.
13. Norder H, Courouce AM, Magnius LO. 1994. Complete genomes, phylogenetic relatedness, and structural proteins of six strains of the hepatitis B virus, four of which represent two new genotypes. Virology 198:489-503.
14. Okamoto HF, Tsuda FF, Sakugawa HF, Sastrosoewignjo RI, Imai MF, Miyakawa YF, Mayumi M. 1988. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 69:2575-2083.
15. Stuyver LF, De Gendt S, Van Geyt CF, Zoulim FF, Fried MF, Schinazi RF, Rossau R. 2000. A new genotype of hepatitis B virus: complete genome and phylogenetic relatedness. J Gen Virol 81:67-74.
16. Van Damme PF, Vorsters A. 2001. Hepatitis B control in Europe by universal vaccination programmes: the situation in 2001. J Med Virol 67:433-439.
17. Van Houdt R, Sonder GJ, Dukers NH, Bovee LP, Van den Hoek JA, Coutinho RA, Bruisten SM. 2006. Impact of a targeted hepatitis B vaccination program in Amsterdam, The Netherlands. Vaccine, doi:10.1016/j.vaccine.2006.06.058.
18. Van Steenbergen JE, Niesters HG, Op de Coul EL, Van Doornum GJ FAU, Osterhaus AD, Leentvaar-Kuijpers AF, Coutinho RA, Van den Hoek JA. 2002. Molecular epidemiology of hepatitis B virus in Amsterdam 1992-1997. J Med Virol 66:159-165.
19. WHO. 2000. Hepatitis B fact sheet 204. http://www.who.int/mediacentre/ factsheets/fs204/en/index.html (accesseds August 9, 2005).
20. Zollner B. 2004. Surveillance of the molecular epidemiology of hepatitis B virus in industrialized countries: necessary despite low prevalence and an available, effective vaccine? Clin Infect Dis 39:953-954.